| Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia F Civeira, E Ros, E Jarauta, N Plana, D Zambon, J Puzo, JPM de Esteban, ... The American journal of cardiology 102 (9), 1187-1193. e1, 2008 | 219 | 2008 |
| Estándares SEA 2022 para el control global del riesgo cardiovascular JM Mostaza, X Pintó, P Armario, L Masana, JT Real, P Valdivielso, ... Clínica e investigación en arteriosclerosis 34 (3), 130-179, 2022 | 217 | 2022 |
| Non-alcoholic fatty liver disease and cardiovascular risk A Brea, J Puzo International journal of cardiology 167 (4), 1109-1117, 2013 | 185 | 2013 |
| Serum chitotriosidase activity is increased in subjects with atherosclerosis disease M Artieda, A Cenarro, A Gañán, I Jericó, C Gonzalvo, JM Casado, I Vitoria, ... Arteriosclerosis, thrombosis, and vascular biology 23 (9), 1645-1652, 2003 | 157 | 2003 |
| Malnutrition screening and assessment C Serón-Arbeloa, L Labarta-Monzón, J Puzo-Foncillas, T Mallor-Bonet, ... Nutrients 14 (12), 2392, 2022 | 107 | 2022 |
| Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia M Solanas-Barca, I de Castro-Orós, R Mateo-Gallego, M Cofán, N Plana, ... Atherosclerosis 222 (2), 449-455, 2012 | 77 | 2012 |
| Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter … R Sola, RM Valls, J Puzo, JR Calabuig, A Brea, A Pedret, D Morina, ... PLoS One 9 (8), e101978, 2014 | 63 | 2014 |
| Estándares SEA 2019 para el control global del riesgo cardiovascular JM Mostaza, X Pintó, P Armario, L Masana, JF Ascaso, P Valdivielso, ... Clínica e Investigación en Arteriosclerosis 31, 1-43, 2019 | 59 | 2019 |
| Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia E Climent, S Pérez-Calahorra, V Marco-Benedí, N Plana, R Sánchez, ... Scientific reports 7 (1), 5596, 2017 | 49 | 2017 |
| Effect of endurance and resistance training on regional fat mass and lipid profile J Perez-Gomez, G Vicente-Rodríguez, IA Royo, D Martínez-Redondo, ... Nutricion hospitalaria 28 (2), 340-346, 2013 | 49 | 2013 |
| Lifestyle factors associated with BMI in a Spanish graduate population: the SUN study MA Alcácera, I Marques-Lopes, M Fajó-Pascual, J Puzo, J Blas Perez, ... Obesity facts 1 (2), 80-87, 2008 | 43 | 2008 |
| Estrategia para el diagnóstico de las dislipidemias. Recomendación 2018 BC Estébanez, MP Mieras, CR Román, JCV Ramírez, ME Salán, ... Revista del Laboratorio Clínico 12 (4), e21-e33, 2019 | 41 | 2019 |
| Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein M Artieda, A Cenarro, A Gañán, A Lukic, E Moreno, J Puzo, M Pocoví, ... Cardiology 108 (4), 297-306, 2007 | 41 | 2007 |
| Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases R Alonso, S Castillo, F Civeira, J Puzo, JJ de la Cruz, M Pocoví, P Mata Medicina Clinica 118 (13), 487-492, 2002 | 41 | 2002 |
| Role of naturally-occurring plant sterols on intestinal cholesterol absorption and plasmatic levels T Sanclemente, I Marques-Lopes, J Puzo, AL Garcia-Otin Journal of physiology and biochemistry 65 (1), 87, 2009 | 40 | 2009 |
| Naturally-occurring phytosterols in the usual diet influence cholesterol metabolism in healthy subjects T Sanclemente, I Marques-Lopes, M Fajó-Pascual, M Cofán, E Jarauta, ... Nutrition, Metabolism and Cardiovascular Diseases 22 (10), 849-855, 2012 | 38 | 2012 |
| Functional analysis of LDLR promoter and 5′ UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia I De Castro‐Orós, S Pampín, A Bolado‐Carrancio, A De Cubas, ... Human mutation 32 (8), 868-872, 2011 | 36 | 2011 |
| A retrospective study about the influence of early nutritional support on mortality and nosocomial infection in the critical care setting C Serón-Arbeloa, J Puzo-Foncillas, T Garcés-Gimenez, J Escós-Orta, ... Clinical nutrition 30 (3), 346-350, 2011 | 36 | 2011 |
| Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia F Civeira, A Cenarro, J Ferrando, J Puzo, AL Garcia-Otín, P Mozas, ... American Heart Journal 138 (1), 156-162, 1999 | 33 | 1999 |
| Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia P Mozas, S Castillo, G Reyes, D Tejedor, F Civeira, I Garcia-Alvarez, ... American heart journal 145 (6), 999-1005, 2003 | 32 | 2003 |
